CORRELATION ANALYSIS OF GSTP1 GENE POLYMORPHISM WITH MORBIDITY OF PRIMARY METASTATIC COLORECTAL CANCER

Yuri Bazhora, Sergii Chetverikov, Viacheslav Onyshchenko, Mykhailo Chetverikov, Valeriia Chetverikova-Ovchynnyk

Abstract


Colorectal cancer (CRC) is one of the most common malignancies. Susceptibility to malignant processes is mediated by genetically driven differences in the effectiveness of detoxification of potential carcinogens. One of the factors that may influence the risk of CRC is the glutathione-S-transferase (GST) gene family that encodes glutathione transferase enzymes. The GSTP1 gene is expressed both in normal and pathological conditions. Determining its specific alleles may be a marker of CRC.

The aim of the research – to study GSTP1 gene polymorphism, which is likely to be more common among patients with primary metastatic colorectal cancer compared with healthy population.

Materials and methods. The study involved 12 patients with primary metastatic colorectal cancer aged 43 to 72 years, the control group was represented by a sample of 31 people without cancer.

Results. The incidence of advanced CRC in the presence of GSPT1 Val / Val (aa) polymorphism is statistically significantly higher than in the presence of Ile / Ile (AA) and Ile / Val (Aa) GSPT1 polymorphism.

Conclusions. Among people with GSTP1 Val / Val (aa) polymorphism, primary CRC is 4.4 times more likely than among people with GSPT1 Ile / Ile (AA) and Ile / Val (Aa) polymorphisms, which are statistically significant (P < 0.05). The obtained results indicate the possibility of conducting a genetic study of GSTP1 polymorphism to form groups of potential risk of CRC.


Keywords


glutathione-S-transferase P1; metastatic colorectal cancer; genetic polymorphism

Full Text:

PDF

References


Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C. et al. (2018). GLOBOCAN 2018 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer.

Van Cutsem, E., Cervantes, A., Nordlinger, B., Arnold, D. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 25, 1–9. doi: http://doi.org/10.1093/annonc/mdu260

Fedorenko, Z. P., Goulak, L. O., Gorokh, Y. L., Ryzhov, A. Y., Soumkina, E. V., Koutsenko, L. B. (2018). Cancer in Ukraine. Available at: www.ncru.inf.ua/publications/ Last accessed: 21.08.2017

Siegel, R. L., Miller, K. D., Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69 (1), 7–34. doi: http://doi.org/10.3322/caac.21551

Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A.-M., Howlader, N. et. al. (2018). Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer, 124 (13), 2785–2800. doi: http://doi.org/10.1002/cncr.31551

Louie, S. M., Grossman, E. A., Crawford, L. A., Ding, L., Camarda, R., Huffman, T. R. et. al. (2016). GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity. Cell Chemical Biology, 23 (5), 567–578. doi: http://doi.org/10.1016/j.chembiol.2016.03.017

Chen, Z. H., Xian, J. F., Luo, L. P. (2017). Association between GSTM1, GSTT1, and GSTP1 polymorphisms and gastric cancer risk, and their interactions with environmental factors. Genetics and Molecular Research, 16 (1). doi: http://doi.org/10.4238/gmr16018877

Shahsavari, G., Amiri, A., Shamaei, M., Adibhesami, G., Emami Razavi, A., Birjandi, M., Pourabdollah, M. (2019). The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People. Asian Pacific Journal of Cancer Prevention, 20 (5), 1503–1509. doi: http://doi.org/10.31557/apjcp.2019.20.5.1503

Sun, Y., Pan, J., Tong, X., Chen, E., Yan, W., Wu, M. et. al. (2019). Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies. Journal of Cancer, 10 (13), 2915–2926. doi: http://doi.org/10.7150/jca.31130

Shen, X., Wang, J., Yan, X., Ren, X., Wang, F., Chen, X., Xu, Y. (2016). Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis. Cancer Chemotherapy and Pharmacology, 77 (6), 1285–1302. doi: http://doi.org/10.1007/s00280-016-3047-1

Sharma, A., Pandey, A., Sharma, S., Chatterjee, I., Mehrotra, R., Sehgal, A., Sharma, J. K. (2014). Genetic polymorphism of glutathione S-transferase P1 (GSTP1) in Delhi population and comparison with other global populations. Meta Gene, 2, 134–142. doi: http://doi.org/10.1016/j.mgene.2013.12.003

Zhang, R., Kang, K. A., Piao, M. J., Kim, K. C., Zheng, J., Yao, C. W. et. al. (2014). Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers. International Journal of Oncology, 45 (3), 1275–1283. doi: http://doi.org/10.3892/ijo.2014.2522

Gorukmez, O., Yakut, T., Gorukmez, O., Sag, S. O., Topak, A., Sahinturk, S., Kanat, O. (2016). Glutathione S-transferase T1, M1 and P1 Genetic Polymorphisms and Susceptibility to Colorectal Cancer in Turkey. Asian Pacific Journal of Cancer Prevention, 17 (8), 3855–3859.

Rodrigues-Fleming, G. H., Fernandes, G. M. de M., Russo, A., Biselli-Chicote, P. M., Netinho, J. G., Pavarino, É. C., Goloni-Bertollo, E. M. (2018). Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer. World Journal of Gastroenterology, 24 (39), 4462–4471. doi: http://doi.org/10.3748/wjg.v24.i39.4462

Saeed, H. M., Alanazi, M. S., Nounou, H. A., Shalaby, M. A., Semlali, A., Azzam, N. et. al. (2013). Cytochrome P450 1A1, 2E1 and GSTM1 Gene Polymorphisms and Susceptibility to Colorectal Cancer in the Saudi Population. Asian Pacific Journal of Cancer Prevention, 14 (6), 3761–3768. doi: http://doi.org/10.7314/apjcp.2013.14.6.3761

Khabaz, M. N., Al-Maghra bi, J. A., Nedjadi, T., Gar, M. A., Bakarman, M., Gazzaz, Z. J., Ibrahim, A. M. (2016). Does Val/Val genotype of GSTP1 enzyme affects susceptibility to colorectal cancer in Saudi Arabia? Neuro Endocrinol Lett, 37, 46–52.

Klusek, J., Nasierowska-Guttmejer, A., Kowalik, A., Wawrzycka, I., Lewitowicz, P., Chrapek, M., Głuszek, S. (2018). GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers. Oncotarget, 9 (30), 21224–21230. doi: http://doi.org/10.18632/oncotarget.25031

Rashid, F., Nissar, S., Sameer, A., Rasool, R., Chowdri, N. (2019). Promoter methylation and Ile105val polymorphism of GSTP1 gene in the modulation of colorectal cancer risk in ethnic Kashmiri population. Indian Journal of Cancer, 56 (3), 248–253. doi: http://doi.org/10.4103/ijc.ijc_11_18

Kassab, A., Msolly, A., Lakhdar, R., Gharbi, O., Miled, A. (2013). Polymorphisms of glutathione-S-transferases M1, T1, P1 and susceptibility to colorectal cancer in a sample of the Tunisian population. Medical Oncology, 31 (1). doi: http://doi.org/10.1007/s12032-013-0760-z

Cong, N., Liu, L., Xie, Y., Shao, W., Song, J. (2014). Association between Glutathione S-Transferase T1, M1, and P1 Genotypes and the Risk of Colorectal Cancer. Journal of Korean Medical Science, 29 (11), 1488–1492. doi: http://doi.org/10.3346/jkms.2014.29.11.1488




DOI: http://dx.doi.org/10.21303/2504-5679.2020.001196

Refbacks

  • There are currently no refbacks.




Copyright (c) 2020 Yuri Bazhora, Sergii Chetverikov, Viacheslav Onyshchenko, Mykhailo Chetverikov, Valeriia Chetverikova-Ovchynnyk

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)